Jones, J F, Streib, J, Baker, S et al. · Journal of medical virology · 1991 · DOI
This study looked at how the immune system responds to Epstein-Barr virus (EBV) in ME/CFS patients compared to healthy people who have been infected with EBV. Researchers found that immune cells from ME/CFS patients were much more likely to grow uncontrollably in the lab (30% vs 8%), and patients showed more signs of active viral infection in their blood. These findings suggest that some ME/CFS patients may have difficulty controlling EBV reactivation.
This research provides early immunological evidence that ME/CFS may involve abnormal immune control of EBV reactivation, a leading hypothesis about disease mechanisms. Understanding whether EBV plays a triggering or perpetuating role in ME/CFS could eventually lead to targeted immune-based treatments. The study's findings have influenced decades of subsequent EBV research in ME/CFS populations.
This study does not prove that EBV causes ME/CFS or that EBV reactivation is present in all ME/CFS patients. The findings show correlation between impaired immune control and active viral markers, but cannot establish causation. The small sample size and open study design limit generalizability, and the results do not explain why only some EBV-infected people develop ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.